Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
<p>Abstract</p> <p>Introduction</p> <p>Central serous chorioretinopathy is characterized by serous neurosensory detachment of the macula and it usually resolves spontaneously with good visual prognosis. In some patients, however, the serous retinal detachment might be v...
Main Authors: | Lai Timothy YY, Wu Zenith HY, Ng Winnie WK |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/5/1/208 |
Similar Items
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
by: Sanguansak T, et al.
Published: (2015-12-01) -
Retrospective study on half-dose verteporfin photodynamic therapy for treatment of chronic central serous chorioretinopathy
by: Xin Sun, et al.
Published: (2015-10-01) -
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
by: Alkin Z, et al.
Published: (2014-04-01) -
Photodynamic therapy with one third-dose verteporfin for treating acute central serous chorioretinopathy
by: Bo Zheng, et al.
Published: (2013-08-01) -
Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
by: Kyoko Fujita, et al.
Published: (2020-12-01)